Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab for Kidney Transplant Desensitization
NCT02500251Phase 2Completed
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in renal transplant rejection (RTR). Started Jun 2015; status: completed.
02
Drugs
belimumab
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT02500251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500251.